Linical Co (TSE:2183) Total Debt per Share: 円99.63 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:2183 Linical Co Ltd TSE:2183
41 GF Score
Price 円207.00
GF Value 円332.89
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Linical Co Total Debt per Share?

Linical Co TSE:2183 +0.98% 41 Total Debt per Share is 円99.63 as of Mar. 2026. GuruFocus rates TSE:2183 with a GF Score™ of 41/100 and a GF Value™ of 円332.89 (Possible Value Trap). The stock has 5 warning signs investors should review.

円99.63 (As of Mar. 2026)

Total Debt per Share is calculated as total debt divided by Shares Outstanding (EOP). Total debt is calculated as Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Linical Co's Total Debt Per Share for the quarter that ended in Mar. 2026 was 円99.63.


Linical Co Total Debt per Share Historical Data

* Premium members only.

The historical data trend for Linical Co's Total Debt per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Linical Co Total Debt per Share Chart

Linical Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Debt per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 181.73 156.83 128.32 103.07 99.63

Linical Co Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Total Debt per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 128.32 114.17 103.07 93.31 99.63
TSE:2183
41GF Score
Linical Co Ltd TSE:2183
Total Debt per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Linical Co Total Debt per Share Calculation

Linical Co's Total Debt Per Share for the fiscal year that ended in Mar. 2026 is calculated as:

Linical Co's Total Debt Per Share for the quarter that ended in Mar. 2026 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Debt per Share →
What does a Total Debt per Share of 円99.63 mean?
Linical Co (TSE:2183) has a Total Debt per Share of 円99.63 as of Mar. 2026. Total debt per share equals the per-share value of a company's long-term and short-term debt. View historical data on Linical Co and its competitors.
Is Linical Co's Total Debt per Share too high?
Linical Co's current Total Debt per Share is 円99.63. Overall, Linical Co has a GF Score™ of 41/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Linical Co's Total Debt per Share compare to VRTX and REGN?
Linical Co's Total Debt per Share of 円99.63 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Debt per Share for a Biotechnology company?
A good Total Debt per Share depends on the Biotechnology industry context. However, Total Debt per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Debt per Share mean?
A high Total Debt per Share can signal that a stock is expensive relative to its fundamentals. Total debt per share equals the per-share value of a company's long-term and short-term debt. View historical data on Linical Co and its competitors. Linical Co's current Total Debt per Share is 円99.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Linical Co stock overvalued right now?
Based on GuruFocus' analysis, Linical Co (TSE:2183) is currently considered Possible Value Trap. The stock's GF Value™ is 円332.89, compared to a current price of 円207.00 — trading 37.8% below its estimated fair value. The current Total Debt per Share is 円99.63. Linical Co's overall GF Score™ is 41/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Debt per Share calculated?
Total Debt per Share is calculated from a company's financial statements. For Linical Co (TSE:2183), the current Total Debt per Share is 円99.63 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Linical Co (TSE:2183) Overvalued in 2026?

Based on GuruFocus' analysis, Linical Co stock appears to be undervalued. The current stock price of 円207.00 is trading 37.8% below its estimated GF Value™ of 円332.89. GuruFocus considers Linical Co to be Possible Value Trap.

Key valuation signals for TSE:2183:

  • Total Debt per Share: 円99.63
  • GF Value™: 円332.89 vs. price of 円207.00 (37.8% below fair value)
  • GF Score™: 41/100 with 5 warning signs

No single metric tells the full story. See the TSE:2183 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Linical Co Business Description

Address 1-6-1 Miyahara, 10th floor, Shin-Osaka Brick Building, Yodogawa-ku, Osaka, JPN, 532-0003
Linical Co Ltd is a pharmaceutical company.
41GF Score

Get the complete analysis for TSE:2183

Total Debt per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円207.00
Price
円332.89
GF Value